Yuankai Shi
Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Beijing Chaoyang Emergency Medical Center(CN)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Lymphoma Diagnosis and Treatment, Colorectal Cancer Treatments and Studies, Lung Cancer Diagnosis and Treatment
Most-Cited Works
- → A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)(2014)1,526 cited
- → Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial(2016)1,159 cited
- → Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non–Small Cell Lung Cancer(2018)605 cited
- → Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial(2013)421 cited
- → Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial(2019)351 cited